Prevention of Peritoneal Metastasis of Human Gastric Cancer Cells in Nude Mice by S-1, a Novel Oral Derivative of 5-Fluorouracil

Publisher： Karger

E-ISSN： 1423-0232|64|2|176-182

ISSN： 0030-2414

Source： Oncology, Vol.64, Iss.2, 2003-02, pp. : 176-182

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phase II Study of S-1, a Novel Oral Derivative of 5-Fluorouracil, in Advanced Gastric Cancer

By  

Oncology, Vol. 58, Iss. 3, 2000-04 ,pp. : 191-197

Karger

Access to resources Recommend Favorite

An Early Phase II Study of Oral S-1, a Newly Developed 5-Fluorouracil Derivative for Advanced and Recurrent Gastrointestinal Cancers

By  

Oncology, Vol. 57, Iss. 3, 1999-10 ,pp. : 202-210

Karger

Access to resources Recommend Favorite

A phase 2 trial of intravenous and intraperitoneal paclitaxel combined with S‐1 for treatment of gastric cancer with macroscopic peritoneal metastasis

By  

CANCER, Vol. 119, Iss. 18, 2013-09 ,pp. : 3354-3358

John Wiley & Sons Inc

Access to resources Recommend Favorite

Peroxisome proliferator activated receptor‐gamma stimulation for prevention of 5‐fluorouracil‐induced oral mucositis in mice

By  

HEAD & NECK: JOURNAL FOR THE SCIENCES & SPECIALTIES OF THE HEAD AND NECK, Vol. 40, Iss. 3, 2018-03 ,pp. : 577-583

John Wiley & Sons Inc

Access to resources Recommend Favorite

Oral fluoropyrimidine versus intravenous 5‐fluorouracil for the treatment of advanced gastric and colorectal cancer: Meta‐analysis

By  

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol. 33, Iss. 1, 2018-01 ,pp. : 209-225

John Wiley & Sons Inc

Access to resources Recommend Favorite